Literature DB >> 24975035

Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma.

Yukiko Niwa1, Suguru Yamada, Masahiko Koike, Mitsuro Kanda, Tsutomu Fujii, Goro Nakayama, Hiroyuki Sugimoto, Shuji Nomoto, Michitaka Fujiwara, Yasuhiro Kodera.   

Abstract

BACKGROUND AND OBJECTIVES: Epithelial to mesenchymal transition (EMT) is considered to play an important role in cancer invasion. Tumor budding is a prognostic factor in esophageal squamous cell carcinoma (ESCC). The aim of this study was to explore the correlation between EMT and tumor budding.
METHODS: Surgical specimens from 78 cases of ESCC resected without preoperative treatment between 2001 and 2013 were enrolled in the study. The mRNA expressions of E-cadherin and vimentin were measured in cancerous tissues using real-time PCR, and each tumor was classified into either epithelial or mesenchymal group. Tumor budding was evaluated in H&E-stained slides and divided into two groups; low-grade budding (<3) and high-grade budding (≥3).
RESULTS: The 5-year survival rate in the epithelial group was significantly higher than that in the mesenchymal group (62.0% vs. 31.5%, P = 0.021). Survival rate of patients in the low-grade budding group was significantly higher than that of patients in the high-grade budding group (75.1% vs. 25.9%, P < 0.001). High-grade tumor budding was significantly associated with the mesenchymal group (P = 0.009).
CONCLUSION: EMT was found to occur in ESCC and was significantly associated with tumor budding. Tumor budding was identified as a significant independent prognostic factor among the current population of ESCC.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  epithelial to mesenchymal transition; esophageal cancer; prognosis; tumor budding

Mesh:

Substances:

Year:  2014        PMID: 24975035     DOI: 10.1002/jso.23694

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  26 in total

1.  Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.

Authors:  Valeria Maffeis; Rocco Cappellesso; Francesca Galuppini; Vincenza Guzzardo; Alessia Zanon; Diego Cazzador; Enzo Emanuelli; Laura Ventura; Alessandro Martini; Ambrogio Fassina
Journal:  Virchows Arch       Date:  2020-01-24       Impact factor: 4.064

2.  AXL is a marker for epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Guoan Zhang; Xia Kong; Meng Wang; Hongli Zhao; Sha Han; Ronghang Hu; Jian Huang; Wen Cui
Journal:  Oncol Lett       Date:  2017-11-20       Impact factor: 2.967

Review 3.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

4.  Low expression of microRNA-202 is associated with the metastasis of esophageal squamous cell carcinoma.

Authors:  Guoliang Ma; Fengmei Zhang; Xueguang Dong; Xiaoli Wang; Yuguo Ren
Journal:  Exp Ther Med       Date:  2016-01-21       Impact factor: 2.447

5.  Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.

Authors:  Yujing Sun; Junyi He; Duan-Bo Shi; Hui Zhang; Xu Chen; Ai-Yan Xing; Peng Gao
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-23       Impact factor: 4.553

6.  Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding.

Authors:  Yaju Feng; Lumeng Wang; Ting Wang; Ying Li; Qingqing Xun; Renya Zhang; Lin Liu; Lei Li; Wei Wang; Yixuan Tian; Lili Yang; Xiao Zhi; Bijiao Zhou; Xin Chen; Tao Sun; Yanrong Liu
Journal:  Mol Ther       Date:  2021-02-10       Impact factor: 12.910

Review 7.  Epithelial to Mesenchymal Transition in a Clinical Perspective.

Authors:  Jennifer Pasquier; Nadine Abu-Kaoud; Haya Al Thani; Arash Rafii
Journal:  J Oncol       Date:  2015-09-06       Impact factor: 4.375

8.  High tumor budding stratifies breast cancer with metastatic properties.

Authors:  Bodour Salhia; Mafalda Trippel; Katrin Pfaltz; Nikola Cihoric; André Grogg; Claudia Lädrach; Inti Zlobec; Coya Tapia
Journal:  Breast Cancer Res Treat       Date:  2015-03-17       Impact factor: 4.872

Review 9.  Tumor Budding: The Name is EMT. Partial EMT.

Authors:  Alexandru Dan Grigore; Mohit Kumar Jolly; Dongya Jia; Mary C Farach-Carson; Herbert Levine
Journal:  J Clin Med       Date:  2016-04-29       Impact factor: 4.241

10.  Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.

Authors:  Bijiao Zhou; Shumin Zong; Weilong Zhong; Yixuan Tian; Lumeng Wang; Qian Zhang; Renya Zhang; Lei Li; Wei Wang; Jianmin Zhao; Xin Chen; Yaju Feng; Binghui Zhai; Tao Sun; Yanrong Liu
Journal:  Oncogene       Date:  2019-11-01       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.